Editas Medicine, Inc. (EDIT) financial statements (2020 and earlier)

Company profile

Business Address 11 HURLEY ST.
CAMBRIDGE, MA 02141
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments457369329185
Cash and cash equivalents238135147185
Short-term investments219234183 
Restricted cash and investments22  
Receivables0010
Prepaid expense 322
Other undisclosed current assets5110
Total current assets:464375332187
Noncurrent Assets
Operating lease, right-of-use asset29
Property, plant and equipment11403940
Other noncurrent assets5522
Total noncurrent assets:45464142
TOTAL ASSETS:509420373229
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28181522
Accounts payable6545
Accrued liabilities22131117
Deferred revenue24
Debt6   
Deferred revenue and credits13 
Contract with customer, liability16
Other liabilities3211
Other undisclosed current liabilities  810
Total current liabilities:60363733
Noncurrent Liabilities
Long-term debt and lease obligation23323335
Capital lease obligations323335
Operating lease, liability23
Liabilities, other than long-term debt1631169526
Deferred revenue and credits9526
Accounts payable and accrued liabilities   0
Deferred revenue163
Contract with customer, liability116
Other liabilities0000
Total noncurrent liabilities:18614812861
Total liabilities:24618416595
Stockholders' equity
Stockholders' equity attributable to parent262236208135
Common stock0000
Additional paid in capital812652514320
Accumulated other comprehensive income (loss)0(0)(0) 
Accumulated deficit(549)(416)(306)(186)
Total stockholders' equity:262236208135
TOTAL LIABILITIES AND EQUITY:509420373229

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenue, net146
Gross profit:2132146
Operating expenses(161)(146)(134)(103)
Operating loss:(141)(114)(120)(97)
Nonoperating income (expense)74(0)0
Investment income, nonoperating73(1)0
Other nonoperating income (expense)(0)01(0)
Net loss attributable to parent:(134)(110)(120)(97)
Preferred stock dividends and other adjustments   (0)
Net loss available to common stockholders, diluted:(134)(110)(120)(97)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(134)(110)(120)(97)
Other comprehensive income (loss)00(0) 
Comprehensive loss, net of tax, attributable to parent:(134)(110)(120)(97)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: